세계의 생분해성 스텐트 시장 : 유형, 전개, 재료, 디자인, 용도, 최종 사용자별 예측(2025-2030년)

The Biodegradable Stents Market was valued at USD 406.78 million in 2023, expected to reach USD 426.39 million in 2024, and is projected to grow at a CAGR of 5.02%, to USD 573.20 million by 2030.

Biodegradable stents, predominantly used in cardiovascular applications, are emerging as an innovative solution designed to provide temporary support to blood vessels and other ducts or passageways before safely dissolving within the body over time. This reduces the long-term complications and need for additional surgeries associated with permanent metal stents. The necessity for biodegradable stents arises from the increasing prevalence of cardiovascular diseases and the demand for minimally invasive, patient-friendly treatments. Applications extend beyond cardiology to areas like urology, orthopedics, and neurology, providing new end-use scopes that can benefit from their temporary functionality.

Market growth is significantly driven by advancements in materials science, increasing research investments, and favorable healthcare policies aiming to reduce medical device footprints. Recent market insights indicate a rising trend in partnerships between medical device manufacturers and biotechnology firms, looking to develop stents with enhanced bio-absorbable properties. Potential opportunities lie in tapping emerging markets in Asia-Pacific and Latin America, spurred by improved healthcare infrastructure and rising health awareness. Emphasizing affordable pricing models and expanding product portfolios to include multi-functional stents can further capture market share. However, limitations include technological complexities and high R&D costs, which can inflate the final product price, coupled with regulatory hurdles that could hamper speed to market.

Challenges such as limited long-term outcome data and skepticism among healthcare professionals regarding the efficacy of such products could slow adoption rates. The best areas for innovation and research include refining polymer compositions to enhance predictability of degradation rates and developing next-generation drug-eluting biodegradable stents that offer improved therapeutic benefits while minimizing procedural risks. The nature of the biodegradable stents market is currently at a nascent growth stage with high potential, characterized by swift technological progress, burgeoning competition, and strategic collaborations. Therefore, businesses that focus on continuous research and agile adaptation to technological trends are likely to thrive in this dynamic environment.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biodegradable Stents Market

The Biodegradable Stents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cardiovascular diseases
  • Shift toward minimally invasive procedures
• Market Restraints
  • High cost associated with biodegradable stents
• Market Opportunities
  • Innovations in stent technology and customization of biodegradable stents
  • Enhanced government support and regulatory approvals
• Market Challenges
  • Product recall and safety concerns associated with biodegradable stents

Porter's Five Forces: A Strategic Tool for Navigating the Biodegradable Stents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biodegradable Stents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biodegradable Stents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biodegradable Stents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biodegradable Stents Market

A detailed market share analysis in the Biodegradable Stents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biodegradable Stents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biodegradable Stents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biodegradable Stents Market

A strategic analysis of the Biodegradable Stents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biodegradable Stents Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Arterial Remodeling Technologies SA, Arterius Ltd, B. Braun Melsungen AG, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, JW Medical Systems LTD, Kaneka Corporation, KLS Martin Group, Kyoto Medical Planning Co. Ltd., Medtronic Plc, Meril Life Sciences Pvt. Ltd., Microport Scientific Corporation, OrbusNeich Medical, Q3 Medical Devices Limited., Reva Medical, SafeGuard Surgical, Inc., Smith & Nephew Plc, Stryker Corporation, Syntellix AG, Terumo Corporation, and Wright Medical Group.

Market Segmentation & Coverage

This research report categorizes the Biodegradable Stents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Coronary Artery Stents, Non-vascular Stents, and Peripheral Artery Stents. The Non-vascular Stents is further studied across Billary Stents and Esophageal Stents.
• Based on Deployment, market is studied across Balloon-Expandable Stents and Self-Expanding Stents.
• Based on Material, market is studied across Ceramic, Metallic, and Polymeric. The Polymeric is further studied across Poly Lactic Acid and Polyglycolic Acid.
• Based on Design, market is studied across Monofilament Stents and Multifilament Stents.
• Based on Application, market is studied across Cardiovascular, Cosmetic Surgery, General Surgery, and Orthopedics.
• Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Centers, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiovascular diseases
    • 5.1.1.2. Shift toward minimally invasive procedures
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with biodegradable stents
  • 5.1.3. Opportunities
    • 5.1.3.1. Innovations in stent technology and customization of biodegradable stents
    • 5.1.3.2. Enhanced government support and regulatory approvals
  • 5.1.4. Challenges
    • 5.1.4.1. Product recall and safety concerns associated with biodegradable stents
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Increasing applications of coronary artery stents in patients with heart disease to ensure adequate blood flow to the heart
  • 5.2.2. Application: Proliferation of use of biodegradable stents in cardiovascular disease to improve blood flow to the heart
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biodegradable Stents Market, by Type

• 6.1. Introduction
• 6.2. Coronary Artery Stents
• 6.3. Non-vascular Stents
  • 6.3.1. Billary Stents
  • 6.3.2. Esophageal Stents
• 6.4. Peripheral Artery Stents

7. Biodegradable Stents Market, by Deployment

• 7.1. Introduction
• 7.2. Balloon-Expandable Stents
• 7.3. Self-Expanding Stents

8. Biodegradable Stents Market, by Material

• 8.1. Introduction
• 8.2. Ceramic
• 8.3. Metallic
• 8.4. Polymeric
  • 8.4.1. Poly Lactic Acid
  • 8.4.2. Polyglycolic Acid

9. Biodegradable Stents Market, by Design

• 9.1. Introduction
• 9.2. Monofilament Stents
• 9.3. Multifilament Stents

10. Biodegradable Stents Market, by Application

• 10.1. Introduction
• 10.2. Cardiovascular
• 10.3. Cosmetic Surgery
• 10.4. General Surgery
• 10.5. Orthopedics

11. Biodegradable Stents Market, by End User

• 11.1. Introduction
• 11.2. Ambulatory Surgical Centers
• 11.3. Cardiac Centers
• 11.4. Hospitals

12. Americas Biodegradable Stents Market

• 12.1. Introduction
• 12.2. Argentina
• 12.3. Brazil
• 12.4. Canada
• 12.5. Mexico
• 12.6. United States

13. Asia-Pacific Biodegradable Stents Market

• 13.1. Introduction
• 13.2. Australia
• 13.3. China
• 13.4. India
• 13.5. Indonesia
• 13.6. Japan
• 13.7. Malaysia
• 13.8. Philippines
• 13.9. Singapore
• 13.10. South Korea
• 13.11. Taiwan
• 13.12. Thailand
• 13.13. Vietnam

14. Europe, Middle East & Africa Biodegradable Stents Market

• 14.1. Introduction
• 14.2. Denmark
• 14.3. Egypt
• 14.4. Finland
• 14.5. France
• 14.6. Germany
• 14.7. Israel
• 14.8. Italy
• 14.9. Netherlands
• 14.10. Nigeria
• 14.11. Norway
• 14.12. Poland
• 14.13. Qatar
• 14.14. Russia
• 14.15. Saudi Arabia
• 14.16. South Africa
• 14.17. Spain
• 14.18. Sweden
• 14.19. Switzerland
• 14.20. Turkey
• 14.21. United Arab Emirates
• 14.22. United Kingdom

15. Competitive Landscape

• 15.1. Market Share Analysis, 2023
• 15.2. FPNV Positioning Matrix, 2023
• 15.3. Competitive Scenario Analysis
  • 15.3.1. Innovative Partnership in Medical Technology: IIT Roorkee Collaborates with Univlabs Technologies to Develop Biodegradable Ureteral Stents
  • 15.3.2. SafeGuard Surgical's LeakGuard Biodegradable Stent Receives FDA Breakthrough Designation Amid Financial Milestone
  • 15.3.3. Strategic Acquisition Enhances Innovations in Coronary Treatment: Kaneka Corporation's Expansion into Biodegradable Stent Market
• 15.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Arterial Remodeling Technologies SA
• 3. Arterius Ltd
• 4. B. Braun Melsungen AG
• 5. BIOTRONIK SE & Co. KG
• 6. Boston Scientific Corporation
• 7. Elixir Medical Corporation
• 8. JW Medical Systems LTD
• 9. Kaneka Corporation
• 10. KLS Martin Group
• 11. Kyoto Medical Planning Co. Ltd.
• 12. Medtronic Plc
• 13. Meril Life Sciences Pvt. Ltd.
• 14. Microport Scientific Corporation
• 15. OrbusNeich Medical
• 16. Q3 Medical Devices Limited.
• 17. Reva Medical
• 18. SafeGuard Surgical, Inc.
• 19. Smith & Nephew Plc
• 20. Stryker Corporation
• 21. Syntellix AG
• 22. Terumo Corporation
• 23. Wright Medical Group